Similar articles

• [The value of VALUE--a hypertension study which compared valsartan with amlodipine. New data support early, optimal blood pressure control for high-risk patients].

  Nilsson PM. Nilsson PM. Lakartidningen. 2004 Jul 22;101(30-31):2426-7. Lakartidningen. 2004. PMID: 15314941 Swedish. No abstract available.
• [VALUE].

  Okura T, Higaki J. Okura T, et al. Nihon Rinsho. 2006 Aug;64 Suppl 6:419-24. Nihon Rinsho. 2006. PMID: 16981573 Review. Japanese. No abstract available.
• VALUE: analysis of results.

  Fretheim A. Fretheim A. Lancet. 2004 Sep 11-17;364(9438):934-5; author reply 935. doi: 10.1016/S0140-6736(04)17015-3. Lancet. 2004. PMID: 15364181 No abstract available.
• Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

  Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A; VALUE trial group. Julius S, et al. Lancet. 2004 Jun 19;363(9426):2022-31. doi: 10.1016/S0140-6736(04)16451-9. Lancet. 2004. PMID: 15207952 Clinical Trial.
• Single-pill combination of amlodipine and valsartan in the management of hypertension.

  Flack JM, Hilkert R. Flack JM, et al. Expert Opin Pharmacother. 2009 Aug;10(12):1979-94. doi: 10.1517/14656560903120899. Expert Opin Pharmacother. 2009. PMID: 19606937 Review.